Status:
RECRUITING
Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
ADHD
Eligibility:
All Genders
8-16 years
Phase:
NA
Brief Summary
The aim of the MiA-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with Attention Deficit Hyperactiv...
Detailed Description
In the MiA-Study, the investigators investigate a newly developed Training program at the interface between neuropsychology and sports science - the Mio-Training - for its efficacy. The aim of the Mio...
Eligibility Criteria
Inclusion
- Informed consent as documented by signature (see Informed Consent Form) of participants and / or one parent / legal guardian
- Age 8-16 years
- A diagnosis of ADHD (mild, moderate or severe)
- Intelligence \>85 (WISC-V short form)
- German or french speaking
- Willingness to perform the assessments without the medication (the study visits will take place without ADHD medication)
Exclusion
- Any other instable neurological condition (e.g. epilepsy) that significantly impairs development
- A severe psychiatric disease (e.g., eating disorder) or severe learning disability that significantly impairs development
- Known or suspected non-compliance
- Inability to follow the procedures of the study, e.g. due to language problems
- Enrolment of the investigator, his/her family members, employees and other dependent persons
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07162831
Start Date
August 1 2025
End Date
August 31 2027
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Insespital, University Hospital Bern
Bern, Switzerland, 3010